300347 Hangzhou Tigermed Consulting
- 63.88
- +1.35+2.16%
Hangzhou Tigermed Consulting News
Tiger Pharmaceuticals: H Share Announcement - Monthly Report on Stock Changes
Tiger Pharmaceuticals: Report for the third quarter of 2024
Tiger Pharmaceuticals: Announcement of Resolutions of the 12th Meeting of the Fifth Board of Directors
Tiger Pharmaceuticals: H Share Announcement - Date of Board Meeting
Tiger Pharmaceuticals: Announcement on the progress of share repurchases
Tiger Pharmaceuticals: Legal Opinion of Beijing Jiayuan Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Hangzhou Tiger Pharmaceutical Technology Co., Ltd.
Tiger Pharmaceuticals: A Comparative Table of Regulations Revision (October 2024)
Tiger Pharmaceuticals: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Tiger Pharmaceuticals: H Share Announcement - Monthly Report on Stock Changes
Tiger Pharmaceuticals: Announcement of Resolutions of the 7th Meeting of the Fifth Board of Supervisors
Tiger Pharmaceuticals: Announcement of Resolutions of the 11th Meeting of the Fifth Board of Directors
Tiger Pharmaceuticals: Announcement on foreign investment and related transactions
Tiger Pharmaceuticals: Announcement on additional pledges for shareholders holding 5% or more of the shares
Tiger Pharmaceuticals: Announcement on the holding of the 3rd Extraordinary General Meeting of Shareholders in 2024
Tiger Pharmaceuticals: H Share Announcement - Monthly Report on Stock Changes
Hangzhou Tigermed Consulting: Announcement about the progress of stock repurchase.
Tiger Pharmaceuticals: 300347 Tiger Pharmaceuticals Investor Activity Research Record 20240830
Tiger Pharmaceuticals: Announcement on the “Double Improvement of Quality and Return” Action Plan
Tiger Pharmaceuticals: Announcement on changing the use of funds raised by H shares
Tiger Pharmaceuticals: Articles of Association (August 2024)
Analysis
Price Target
No Data
No Data